about
Role of endothelin in uteroplacental circulation and fetal vascular functionTreatment of poor placentation and the prevention of associated adverse outcomes--what does the future hold?Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia.Gestational hypoxia up-regulates protein kinase C and inhibits calcium-activated potassium channels in ovine uterine arteries.Systemic inflammatory stimulation by microparticles derived from hypoxic trophoblast as a model for inflammatory response in preeclampsia.A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin depositionSildenafil Prevents Apoptosis of Human First-Trimester Trophoblast Cells Exposed to Oxidative Stress: Possible Role for Nitric Oxide Activation of 3',5'-cyclic Guanosine Monophosphate SignalingAssociation between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia.Emerging drugs for preeclampsia--the endothelium as a targetSildenafil Treatment Ameliorates the Maternal Syndrome of Preeclampsia and Rescues Fetal Growth in the Dahl Salt-Sensitive Rat.Chronic hypoxia suppresses pregnancy-induced upregulation of large-conductance Ca2+-activated K+ channel activity in uterine arteriesPregnancy Complications and Later Development of Hypertension.Heme oxygenase in pregnancy and preeclampsiaTranslational studies for exercise in high-risk pregnancy: Pre-eclampsia model.From apelin to exercise: emerging therapies for management of hypertension in pregnancy.STOX1: a new player in preeclampsia?How does preeclampsia affect neonates? Highlights in the disease's immunity.Phosphodiesterase type 5 and cancers: progress and challenges.Impairment of BKca channels in human placental chorionic plate arteries is potentially relevant to the development of preeclampsia.Maternal aging affects life performance of progeny in a Holstein dairy cow model.The effects of sildenafil citrate on urinary podocin and nephrin mRNA expression in an L-NAME model of pre-eclampsia.The favorable effects of garlic intake on metabolic profiles, hs-CRP, biomarkers of oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia: randomized, double-blind, placebo-controlled trial.Association between polymorphisms in DNA repair genes (XRCC1 and XRCC7) and risk of preeclampsia.
P2860
Q26828020-1422C99C-BD94-4C93-A2A0-3131A61451EFQ26998662-9F6FA491-6257-4529-8595-631036FEDEC4Q30576991-37C2E10A-47DF-49AE-854C-1CF390AF274DQ33843854-40068770-24ED-4731-9332-16ACBFB3C214Q34164052-8035B5C1-C364-440F-B368-EAEBE982D9BEQ34490667-6F6E3F46-76E3-4E03-BA4B-06DC0130E396Q35178348-574CFD66-D00B-4E81-B62E-0E9552A79DBEQ35395483-C5AE125C-EFA6-4F55-9D2D-820F4CA5E1F6Q35853161-079D08F1-4FC9-4A0D-8820-46B6FC9C69A6Q36055507-0833DC02-917F-47AD-949A-28FB7109E0B4Q36420578-DF3939BD-E191-4265-ACF9-E42D550DAA84Q36576619-8F668CCF-67B5-4E33-9E7A-614EE6DF8831Q36582232-4BF1ED3F-A31E-4117-904D-21AAA397C1DAQ37057315-9674EECA-7FF4-4176-A1FC-AE417947C248Q37312044-B02D25B8-6B8C-40CD-B866-6FC0D53F9D5DQ38829613-46D23244-ADB9-4A63-887E-3D857980307AQ39223093-6BB74EC7-5294-4C90-8ABA-4A2F1EC4DD8DQ42947320-A4E7F34F-5B18-49E1-A9AC-374AA50D13A6Q46301669-17813227-5A5B-4C8F-AC94-5701082AC0D8Q47171803-966E25B9-CCB0-4908-A9FC-771253083FC3Q47837581-ECFC9C48-844A-49CE-915E-D429D0DC0C31Q50644404-84634203-1A3B-4633-878C-83A912F58D35Q51249136-3C07FBB0-9A5E-4311-A222-508103F49854Q51314191-C4A4A08F-FD0B-4812-8DF9-BD715871DAFEQ54495244-CB578B55-9056-45DA-AFE4-2CE6EEDD8C71
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms and potential therapies for preeclampsia
@en
Mechanisms and potential therapies for preeclampsia.
@nl
type
label
Mechanisms and potential therapies for preeclampsia
@en
Mechanisms and potential therapies for preeclampsia.
@nl
prefLabel
Mechanisms and potential therapies for preeclampsia
@en
Mechanisms and potential therapies for preeclampsia.
@nl
P2860
P1476
Mechanisms and potential therapies for preeclampsia
@en
P2093
Eric M George
Joey P Granger
P2860
P2888
P304
P356
10.1007/S11906-011-0204-0
P577
2011-08-01T00:00:00Z